US giant Merck has signed a new framework agreement with Israel’s Weizmann Institute to research new solutions in the area of biotechnology and cancer research. Merck has more than 300 employees at four sites throughout Israel.
http://www.timesofisrael.com/merck-weizmann-institute-sign-strategic-deal-on-cancer-research/